New obesity drug KAI-9531 takes on semaglutide in major trial
NCT ID NCT07284979
First seen Jan 02, 2026 · Last updated Apr 24, 2026 · Updated 14 times
Summary
This study tests a new weekly injection called KAI-9531 to help people with obesity lose weight. About 1,200 adults with a BMI of 35 or higher who do not have diabetes will receive either KAI-9531, semaglutide (a current weight-loss drug), or a placebo. The main goal is to see how much weight they lose over 76 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kailera Clinical Site
RECRUITINGGlendale, Arizona, 85308, United States
-
Kailera Clinical Site
RECRUITINGPhoenix, Arizona, 85012, United States
-
Kailera Clinical Site
RECRUITINGLittle Rock, Arkansas, 72205, United States
-
Kailera Clinical Site
RECRUITINGNorthridge, California, 91325, United States
-
Kailera Clinical Site
RECRUITINGOceanside, California, 92058, United States
-
Kailera Clinical Site
RECRUITINGHamden, Connecticut, 06517, United States
-
Kailera Clinical Site
RECRUITINGStamford, Connecticut, 06905, United States
-
Kailera Clinical Site
RECRUITINGOrange City, Florida, 32763, United States
-
Kailera Clinical Site
RECRUITINGAlbany, Georgia, 31707, United States
-
Kailera Clinical Site
RECRUITINGChicago, Illinois, 60640, United States
-
Kailera Clinical Site
RECRUITINGNewton, Kansas, 67114, United States
-
Kailera Clinical Site
RECRUITINGShreveport, Louisiana, 71105, United States
-
Kailera Clinical Site
RECRUITINGFarmington Hills, Michigan, 48334, United States
-
Kailera Clinical Site
RECRUITINGMissoula, Montana, 59804, United States
-
Kailera Clinical Site
RECRUITINGLas Vegas, Nevada, 89148, United States
-
Kailera Clinical Site
RECRUITINGAlbany, New York, 12203, United States
-
Kailera Clinical Site
RECRUITINGMorehead City, North Carolina, 28557, United States
-
Kailera Clinical Site
RECRUITINGNorman, Oklahoma, 73069, United States
-
Kailera Clinical Site
RECRUITINGEast Greenwich, Rhode Island, 02818, United States
-
Kailera Clinical Site
RECRUITINGNorth Charleston, South Carolina, 29405, United States
-
Kailera Clinical Site
RECRUITINGSpartanburg, South Carolina, 29303, United States
-
Kailera Clinical Site
RECRUITINGBrownsville, Texas, 78526, United States
-
Kailera Clinical Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Kailera Clinical Site
RECRUITINGManassas, Virginia, 20110, United States
-
Kailera Clinical Site
RECRUITINGRichmond, Virginia, 23236, United States
Conditions
Explore the condition pages connected to this study.